Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Davita Healthcare Partners Inc (DVA)
Davita Healthcare Partners Inc (DVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,074,308
  • Shares Outstanding, K 91,300
  • Annual Sales, $ 11,610 M
  • Annual Income, $ 560,400 K
  • 60-Month Beta 0.98
  • Price/Sales 0.78
  • Price/Cash Flow 6.57
  • Price/Book 6.59
Trade DVA with:

Options Overview Details

View History
  • Implied Volatility 28.38% ( -1.10%)
  • Historical Volatility 36.93%
  • IV Percentile 29%
  • IV Rank 15.94%
  • IV High 55.10% on 10/11/23
  • IV Low 23.31% on 09/01/23
  • Put/Call Vol Ratio 0.11
  • Today's Volume 4,435
  • Volume Avg (30-Day) 7,126
  • Put/Call OI Ratio 1.29
  • Today's Open Interest 85,673
  • Open Int (30-Day) 92,460

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate 1.50
  • Number of Estimates 4
  • High Estimate 1.67
  • Low Estimate 1.33
  • Prior Year 1.11
  • Growth Rate Est. (year over year) +35.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
75.47 +32.48%
on 10/30/23
100.29 -0.31%
on 11/24/23
+23.21 (+30.23%)
since 10/27/23
3-Month
71.51 +39.81%
on 10/11/23
104.16 -4.01%
on 09/21/23
-0.57 (-0.57%)
since 08/28/23
52-Week
69.55 +43.75%
on 11/30/22
116.97 -14.53%
on 08/07/23
+27.90 (+38.71%)
since 11/28/22

Most Recent Stories

More News
Roblox, DaVita rise; Toast, Lucid Group fall, Wednesday, 11/8/2023

Stocks that traded heavily or had substantial price changes on Wednesday Roblox, DaVita rise; Toast, Lucid Group fall

MASI : 92.89 (-2.51%)
DVA : 99.92 (+0.53%)
AAXN : 174.54 (+2.51%)
UPWK : 14.27 (+1.49%)
AMZN : 146.98 (-0.51%)
DaVita (DVA) Q3 2023 Earnings Call Transcript

DVA earnings call for the period ending September 30, 2023.

DVA : 99.92 (+0.53%)
Stocks Close Lower on Heightened Geopolitical Risks and Soaring Bond Yields

What you need to know… The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed down -1.34%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.98%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed...

$SPX : 4,549.56 (-0.02%)
SPY : 454.84 (+0.08%)
$DOWI : 35,419.65 (+0.24%)
DIA : 354.13 (+0.23%)
$IUXX : 15,974.28 (+0.08%)
QQQ : 390.13 (+0.25%)
ALB : 124.09 (+2.74%)
UAL : 39.01 (-0.51%)
AAL : 12.16 (-0.16%)
ALK : 36.90 (+0.16%)
DAL : 36.07 (+0.64%)
LCID : 4.39 (+4.77%)
DaVita Collaborates with Google Cloud to Develop Customized Clinical Operating System Designed to Transform Kidney Care

/PRNewswire/ -- DaVita Inc. (NYSE: DVA) and Google Cloud today announced that the organizations have collaborated to create a new clinical operating system...

DVA : 99.92 (+0.53%)
DaVita Inc. Schedules 3rd Quarter 2023 Investor Conference Call

/PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Tuesday, November...

DVA : 99.92 (+0.53%)
DaVita Statement on GLP-1 and Potential Implications on Chronic Kidney Disease

/PRNewswire/ -- DaVita issued the following statement in response to news this week from Novo Nordisk, manufacturer of Ozempic®, a glucagon-like peptide 1...

DVA : 99.92 (+0.53%)
Stocks Climb Before the Open as Bond Yields Fall, U.S. Inflation Data Looms

December S&P 500 futures (ESZ23) are up +0.43%, and December Nasdaq 100 E-Mini futures (NQZ23) are up +0.46% this morning as U.S. Treasury yields continued to fall, while market participants braced for...

ESZ23 : 4,561.50 (+0.01%)
NQZ23 : 16,026.00 (+0.11%)
GOOGL : 137.15 (+0.54%)
META : 339.22 (+1.35%)
AMGN : 265.54 (+0.48%)
XOM : 103.93 (-0.03%)
DVA : 99.92 (+0.53%)
BAX : 36.35 (-0.19%)
FAST : 59.94 (-1.66%)
DAL : 36.07 (+0.64%)
WBA : 19.97 (-0.70%)
DPZ : 387.83 (+0.20%)
Stocks Settle Higher as Bond Yields Fall on Dovish Fed Comments

What you need to know… The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed up +0.43%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.19%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed...

$SPX : 4,549.56 (-0.02%)
SPY : 454.84 (+0.08%)
$DOWI : 35,419.65 (+0.24%)
DIA : 354.13 (+0.23%)
$IUXX : 15,974.28 (+0.08%)
QQQ : 390.13 (+0.25%)
AMGN : 265.54 (+0.48%)
COHR : 36.13 (-0.36%)
ADBE : 623.29 (+0.65%)
VTR : 45.53 (+0.53%)
CZR : 45.20 (-1.70%)
BA : 222.55 (+1.48%)
Voxx International, Walgreens rise; Exxon Mobil, DaVita fall, Wednesday, 10/11/2023

Stocks that traded heavily or had substantial price changes on Wednesday:

DVA : 99.92 (+0.53%)
PLUG : 3.86 (+12.87%)
XOM : 103.93 (-0.03%)
WBA : 19.97 (-0.70%)
AZZ : 48.09 (-1.68%)
PNCOF : 0.5700 (unch)
PIO : 36.18 (+0.09%)
PNCOY : 0.5100 (-16.39%)
VOXX : 11.25 (+1.26%)
HUM : 510.59 (-0.02%)
Why Dialysis Stocks Plunged Today

Novo Nordisk indicated one of its diabetes drugs could also be used to treat kidney disease. Here's what investors need to know.

NVO : 101.42 (-2.36%)
DVA : 99.92 (+0.53%)
OM : 4.91 (-2.39%)
FMS : 20.42 (+1.04%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals...

See More

Key Turning Points

3rd Resistance Point 101.43
2nd Resistance Point 100.80
1st Resistance Point 100.10
Last Price 99.92
1st Support Level 98.77
2nd Support Level 98.14
3rd Support Level 97.44

See More

52-Week High 116.97
Last Price 99.92
Fibonacci 61.8% 98.86
Fibonacci 50% 93.26
Fibonacci 38.2% 87.66
52-Week Low 69.55

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar